Century Therapeutics, Inc. (IPSC)
2.12
+0.05
(+2.42%)
USD |
NASDAQ |
Aug 24, 16:00
2.115
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Debt to Equity Ratio : 0.1664 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1664 |
| March 31, 2026 | 0.1814 |
| December 31, 2025 | 0.2741 |
| September 30, 2025 | 0.2549 |
| June 30, 2025 | 0.2453 |
| March 31, 2025 | 0.2191 |
| December 31, 2024 | 0.3336 |
| September 30, 2024 | 0.279 |
| June 30, 2024 | 0.2538 |
| March 31, 2024 | 0.2612 |
| December 31, 2023 | 0.2607 |
| September 30, 2023 | 0.217 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.1697 |
| March 31, 2023 | 0.1878 |
| December 31, 2022 | 0.1632 |
| September 30, 2022 | 0.1432 |
| June 30, 2022 | 0.1152 |
| March 31, 2022 | 0.0632 |
| December 31, 2021 | 0.0634 |
| September 30, 2021 | 0.0582 |
| June 30, 2021 | 0.0548 |
| March 31, 2021 | 0.1011 |
| December 31, 2020 | 0.2048 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Exicure, Inc. | 0.00 |
| Absci Corp. | 0.0156 |
| Celularity, Inc. | -1.963 |
| Cardio Diagnostics Holdings, Inc. | 0.0498 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 287.01M |
| Total Liabilities (Quarterly) | 54.66M |
| Shareholders Equity (Quarterly) | 232.34M |
| Current Ratio | 8.280 |
| Net Debt Paydown Yield | 0.63% |